B Dobosz

401 total citations
9 papers, 328 citations indexed

About

B Dobosz is a scholar working on Pathology and Forensic Medicine, Neurology and Physiology. According to data from OpenAlex, B Dobosz has authored 9 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Neurology and 4 papers in Physiology. Recurrent topics in B Dobosz's work include Multiple Sclerosis Research Studies (5 papers), Alzheimer's disease research and treatments (3 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). B Dobosz is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Alzheimer's disease research and treatments (3 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). B Dobosz collaborates with scholars based in Poland. B Dobosz's co-authors include Zbigniew Stelmasiak, Joanna Iłżecka, Halina Bartosik-Psujek, Konrad Rejdak, Z Stelmasiak, Krystyna Mitosek‐Szewczyk, Maria Kozioł-Montewka, Paweł Grieb, Gavin Giovannoni and Tomasz Kocki and has published in prestigious journals such as Neuroscience Letters, Cytokine and Acta Neurologica Scandinavica.

In The Last Decade

B Dobosz

9 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B Dobosz Poland	7	109	92	86	82	65	9	328
Krizia Sanna Italy	8	65 0.6×	46 0.5×	27 0.3×	137 1.7×	77 1.2×	9	298
Sara Balletta Italy	7	67 0.6×	34 0.4×	26 0.3×	95 1.2×	81 1.2×	9	255
Seray Demir Germany	7	99 0.9×	50 0.5×	26 0.3×	75 0.9×	76 1.2×	9	282
Marina Ziehn United States	8	241 2.2×	43 0.5×	20 0.2×	55 0.7×	150 2.3×	16	397
Assia Fafouri France	5	21 0.2×	23 0.3×	35 0.4×	117 1.4×	83 1.3×	6	328
Camila Fernández‐Zapata Germany	7	33 0.3×	20 0.2×	59 0.7×	75 0.9×	169 2.6×	12	273
Melinda Czéh Germany	5	23 0.2×	28 0.3×	46 0.5×	84 1.0×	161 2.5×	6	401
Lori Lebson United States	8	36 0.3×	27 0.3×	37 0.4×	148 1.8×	172 2.6×	15	436
Pernille M. Madsen Denmark	8	109 1.0×	31 0.3×	20 0.2×	132 1.6×	210 3.2×	10	425
Qi Wan China	11	12 0.1×	43 0.5×	26 0.3×	114 1.4×	59 0.9×	14	313

Countries citing papers authored by B Dobosz

Since Specialization

Citations

This map shows the geographic impact of B Dobosz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Dobosz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Dobosz more than expected).

Fields of papers citing papers by B Dobosz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Dobosz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Dobosz. The network helps show where B Dobosz may publish in the future.

Co-authorship network of co-authors of B Dobosz

This figure shows the co-authorship network connecting the top 25 collaborators of B Dobosz. A scholar is included among the top collaborators of B Dobosz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Dobosz. B Dobosz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Bartosik-Psujek, Halina, et al.. (2004). Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine. Acta Neurologica Scandinavica. 109(6). 390–392. 46 indexed citations

2.

Iłżecka, Joanna, Zbigniew Stelmasiak, & B Dobosz. (2002). TRANSFORMING GROWTH FACTOR-BETA 1 (TGF-BETA 1) IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS. Cytokine. 20(5). 239–243. 68 indexed citations

3.

Rejdak, Konrad, Halina Bartosik-Psujek, B Dobosz, et al.. (2002). Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients. Neuroscience Letters. 331(1). 63–65. 89 indexed citations

4.

Iłżecka, Joanna, Z Stelmasiak, & B Dobosz. (2002). [Matrix metalloproteinase-9 (MMP-9) activity in cerebrospinal fluid of amyotrophic lateral sclerosis patients].. PubMed. 35(6). 1035–43. 7 indexed citations

5.

Stelmasiak, Zbigniew, Maria Kozioł-Montewka, B Dobosz, & Konrad Rejdak. (2002). IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients.. PubMed. 7(5). 914–8. 22 indexed citations

6.

Stelmasiak, Zbigniew, Maria Kozioł-Montewka, B Dobosz, et al.. (2001). Interleukin-6 concentration in serum and cerebrospinal fluid in multiple sclerosis patients.. PubMed. 6(6). 1104–8. 60 indexed citations

7.

Iłżecka, Joanna, Z Stelmasiak, & B Dobosz. (2001). Interleukin-1β converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients. Acta Neurologica Scandinavica. 103(4). 255–258. 32 indexed citations

8.

Bartosik-Psujek, Halina, et al.. (2000). The levels of C3 and C4 components of the complement in the sera of relapsing-remitting multiple sclerosis patients (RR-MS) treated by 2-CDA (cladribine).. PubMed. 55. 231–4. 1 indexed citations

9.

Iłżecka, Joanna & B Dobosz. (1998). [Acute phase proteins: alpha-1-acid glycoprotein (AGP) and alpha-1 antichymotrypsin (ACT) in serum of patients with cerebral ischemic stroke].. PubMed. 32(3). 495–502. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact